查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1951308

器官保存市場－全球產業規模、佔有率、趨勢、機會及預測（按解決方案、技術、器官類型、最終用戶、地區和競爭格局分類，2021-2031年）

Organ Preservation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Solution, By Technique, By Organ Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球器官保存市場預計將從 2025 年的 2.8481 億美元成長到 2031 年的 3.8716 億美元，年複合成長率為 5.25%。

該市場涵蓋先進的機械灌注系統和專用化學溶液，旨在維持捐贈器官在保存和運輸過程中的生理功能和細胞活力。推動這一市場成長的關鍵因素包括全球慢性疾病（如心血管疾病和糖尿病）發病率的上升，這些疾病顯著增加了末期器官衰竭的風險。此外，人口老化加劇，以及使得高風險捐贈者器官移植成為可能的臨床突破，都推動了對可靠保存技術的需求，以確保良好的移植後效果。

市場概覽
預測期 2027-2031
市場規模：2025年 2.8481億美元
市場規模：2031年 3.8716億美元
複合年成長率：2026-2031年 5.25%
成長最快的細分市場 威斯康辛大學解決方案（UW Solutions）
最大的市場 北美洲

儘管有這些成長要素，但市場仍面臨一個重大障礙：可供移植的捐贈器官供應有限，而移植需求卻居高不下，兩者之間存在持續缺口。這種短缺限制了手術總數，也限制了器官保存解決方案的潛在市場。根據聯合國器官捐贈網路（UNOS）的數據，2024年美國器官移植手術數量達到創紀錄的48,149例（比上年成長3.3%），但這一數字仍然不足以滿足大量等待救命手術的患者的需求。

市場促進因素

常溫和低溫機械灌注技術的突破正在改變整個產業，使器官存活時間遠遠超出傳統靜態冷藏的限制。這些先進的機械系統在運輸過程中提供持續的代謝支持和監測，減輕缺血性損傷，並使以往無法使用的擴大標準供體器官得以利用。這些動態保存技術的商業性成功體現在主要產業參與者的財務表現上。例如，TransMedics Group, Inc.在2024年10月公佈，其第三季收入淨額年增64%至1.088億美元，這主要得益於其專有器官護理系統的日益普及。

同時，政府的各項措施和旨在促進器官捐贈者登記的國家策略，正推動需要器官保存技術的移植手術數量增加。衛生部門正在簡化捐贈流程並加強基礎設施建設，從而增加器官供應。這帶動了對器官運輸設備和保存耗材的需求。根據英國國家醫療服務體系（NHS）血液和移植服務中心2024年7月發布的報告，英國2023/24會計年度的遺體捐贈者人數將達到1510人，增幅達6%。臨床活動的增加也推動了市場整合，例如，Getinge AB公司於2024年以約4.77億美元的價格收購了Paragonix Technologies公司，將其先進的器官保存設備納入其醫療保健產品組合。

市場挑戰

適當的捐贈器官嚴重短缺仍然是全球器官保存市場擴張的一大障礙。有限的器官供應與巨大的移植需求之間持續存在的不平衡限制了該行業的成長潛力。由於保存技術僅在獲取器官進行運輸時使用，因此市場成長本質上與捐贈率相關，而非終末期器官衰竭患者總數。因此，這些專用灌注系統和解決方案的市場機會受到實際移植手術數量有限的限制。

這種差距的嚴重性顯而易見：器官捐贈組織協會預測，到2025年，日本等待器官移植的人數將超過10.4萬人。這個數字凸顯了可用資源與臨床需求之間的脫節，等待移植的患者人數遠遠超過捐贈者人數。這限制了儲存設備製造商的收入潛力，也阻礙了市場充分利用全球慢性病流行所帶來的需求。

市場趨勢

外包模式和器官移植服務的興起正在重塑市場模式。市場關注點正從購買大型設備轉向提供全面的物流支持，移植中心和醫院擴大採用承包服務網路，負責器官獲取、灌注和運輸，從而顯著減輕手術團隊的工作量。這種轉變使醫療機構無需在硬體和專業人員方面進行大量前期投資，即可利用先進的灌注技術。例如，《醫療採購商》（Medical Buyer）在2025年10月報道稱，TransMedics集團的季度收入成長了32%，達到1.438億美元。這主要得益於該公司擴大了對國家器官移植服務計劃（NOP）物流網路的使用，而不僅僅是主機銷售。

同時，自動化和攜帶式器官運輸系統的進步正在徹底改變捐贈器官的運輸方式，並改善移植後的預後。與傳統的靜態冷藏不同，這些先進設備能夠在運輸過程中主動調節和監測器官的環境，從而提供顯著降低長期臨床風險的保護。將溫度控制和持續監測功能整合到攜帶式設備中，已在提高器官存活率方面展現出實際的好處。器官捐贈聯盟 (ODA) 於 2025 年 6 月發布的 GUARDIAN-Heart 註冊數據顯示，使用 Paragonix SherpaPak 系統保存的心臟，與使用傳統冰塊保存的心臟相比，四年死亡率降低了 54%。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球器官保存市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 解決方案提供者（威斯康辛大學解決方案 (UW Solutions)、Custodial HTK、 Perfadex、其他解決方案）
    • 依技術分類（靜態冷凍保存、低溫機械灌注、常溫機械灌注）
    • 依器官類型（腎臟、肝臟、肺臟、心臟、胰臟）
    • 依最終使用者（器官移植中心、醫院、專科診所）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美器官保存市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲器官保存市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區器官保存市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲器官保存市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美器官保存市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球器官保存市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Paragonix Technologies, Inc
  • XVIVO Perfusion AB
  • Dr. Franz KOhler Chemie GmbH
  • OrganOx Limited
  • Bridge to Life（Europe）Ltd.
  • Waters Medical Systems, LLC
  • Preservation Solutions Inc.
  • Artivion, Inc
  • Vascular Perfusion Solutions, Inc
  • Global Transplant Solutions

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23227

The Global Organ Preservation Market is projected to expand from a valuation of USD 284.81 Million in 2025 to USD 387.16 Million by 2031, progressing at a CAGR of 5.25%. This market consists of advanced mechanical perfusion systems and specialized chemical solutions designed to sustain the physiological function and cellular viability of donor organs during storage and transport. Key factors driving this growth include the rising global incidence of chronic conditions, such as cardiovascular disorders and diabetes, which significantly heighten the risk of end-stage organ failure. Additionally, the increasing geriatric population, combined with clinical breakthroughs that allow for the transplantation of higher-risk donor organs, is fueling the demand for reliable preservation technologies to secure positive post-transplant results.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 284.81 Million
Market Size 2031USD 387.16 Million
CAGR 2026-20315.25%
Fastest Growing SegmentUniversity of Wisconsin Solution (UW Solution)
Largest MarketNorth America

Despite these growth drivers, the market faces a substantial obstacle in the form of a persistent gap between the limited supply of viable donor organs and the high demand for transplants. This shortage restricts the total number of procedures, thereby limiting the addressable market for preservation solutions. Data from the United Network for Organ Sharing indicates that while a record 48,149 organ transplants were conducted in the United States in 2024-a 3.3 percent rise from the prior year-this volume is still inadequate to meet the needs of the extensive waiting list of patients requiring life-saving surgeries.

Market Driver

Technological breakthroughs in normothermic and hypothermic machine perfusion are transforming the industry by extending organ viability far beyond the limits of conventional static cold storage. These advanced mechanical systems provide continuous metabolic support and monitoring during transit, reducing ischemic damage and enabling the use of organs from extended criteria donors that were once considered unusable. The commercial success of these dynamic preservation methods is reflected in the financial performance of key industry players; for example, TransMedics Group, Inc. reported in October 2024 that their third-quarter net revenue surged to USD 108.8 million, a 64 percent increase year-over-year, largely attributed to the increased adoption of their proprietary organ care systems.

Simultaneously, government efforts and national strategies designed to boost donor registration are increasing the number of procedures that require preservation technologies. By streamlining donation processes and enhancing infrastructure, health authorities are effectively increasing organ availability, which in turn drives demand for transport units and preservation consumables. According to a July 2024 report by NHS Blood and Transplant, the United Kingdom saw the number of deceased donors rise to 1,510 in the 2023/24 fiscal year, a 6 percent increase. This rise in clinical activity is also spurring market consolidation, illustrated by Getinge AB's 2024 agreement to acquire Paragonix Technologies for approximately USD 477 million to incorporate advanced preservation devices into its medical portfolio.

Market Challenge

The severe shortage of appropriate donor organs remains a significant barrier to the expansion of the Global Organ Preservation Market. This ongoing imbalance between the finite supply of organs and the high demand for transplantation creates a ceiling on the industry's growth potential. Because preservation technologies are utilized only when an organ is procured for transport, market growth is inherently linked to donation rates rather than the sheer volume of patients suffering from end-stage organ failure. As a result, the market opportunity for these specialized perfusion systems and solutions is constrained by the limited number of transplant procedures actually performed.

The extent of this disparity highlights the severity of the issue, with the Association of Organ Procurement Organizations noting that over 104,000 patients are on the national waiting list for transplants in 2025. This figure emphasizes the disconnect between available resources and clinical necessity, as the number of candidates vastly outnumbers the donor pool. Consequently, revenue potential for manufacturers of preservation devices is capped, preventing the market from fully capitalizing on the demand suggested by the global prevalence of chronic diseases.

Market Trends

The market is being reshaped by the rise of outsourcing models and organ care services, moving the focus from capital equipment purchases to comprehensive logistical support. Transplant centers and hospitals are increasingly utilizing turnkey service networks that handle the entire process of organ retrieval, perfusion, and transport, significantly easing the operational load on surgical teams. This shift allows medical institutions to leverage advanced perfusion technologies without heavy upfront investments in hardware or specialized staff; illustrating this trend, Medical Buyer reported in October 2025 that TransMedics Group achieved a 32 percent quarterly revenue increase to USD 143.8 million, driven largely by the growing use of its National OCS Program (NOP) logistics network rather than console sales alone.

In parallel, the advancement of automated and portable organ transport systems is revolutionizing donor organ mobility and improving post-transplant outcomes. Unlike traditional static cold storage, these sophisticated devices actively regulate and monitor the organ's environment during transport, providing protection that substantially lowers long-term clinical risks. Integrating temperature control and continuous monitoring into a portable unit is yielding tangible survival benefits; the Organ Donation Alliance reported in June 2025 that data from the GUARDIAN-Heart Registry showed a 54 percent reduction in four-year mortality rates for hearts preserved with the Paragonix SherpaPak System compared to those transported using standard ice storage.

Key Market Players

  • Paragonix Technologies, Inc
  • XVIVO Perfusion AB
  • Dr. Franz KOhler Chemie GmbH
  • OrganOx Limited
  • Bridge to Life (Europe) Ltd.
  • Waters Medical Systems, LLC
  • Preservation Solutions Inc.
  • Artivion, Inc
  • Vascular Perfusion Solutions, Inc
  • Global Transplant Solutions

Report Scope

In this report, the Global Organ Preservation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Preservation Market, By Solution

  • University of Wisconsin Solution (UW Solution)
  • Custodial HTK
  • Perfadex
  • Other Solutions

Organ Preservation Market, By Technique

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

Organ Preservation Market, By Organ Type

  • Kidney
  • Liver
  • Lung
  • Heart
  • Pancreas

Organ Preservation Market, By End User

  • Organ Transplant Centers
  • Hospitals
  • Specialty Clinics

Organ Preservation Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Organ Preservation Market.

Available Customizations:

Global Organ Preservation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ Preservation Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Solution (University of Wisconsin Solution (UW Solution), Custodial HTK, Perfadex, Other Solutions)
    • 5.2.2. By Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion)
    • 5.2.3. By Organ Type (Kidney, Liver, Lung, Heart, Pancreas)
    • 5.2.4. By End User (Organ Transplant Centers, Hospitals, Specialty Clinics)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Organ Preservation Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Solution
    • 6.2.2. By Technique
    • 6.2.3. By Organ Type
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Organ Preservation Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Solution
        • 6.3.1.2.2. By Technique
        • 6.3.1.2.3. By Organ Type
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Organ Preservation Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Solution
        • 6.3.2.2.2. By Technique
        • 6.3.2.2.3. By Organ Type
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Organ Preservation Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Solution
        • 6.3.3.2.2. By Technique
        • 6.3.3.2.3. By Organ Type
        • 6.3.3.2.4. By End User

7. Europe Organ Preservation Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Solution
    • 7.2.2. By Technique
    • 7.2.3. By Organ Type
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Organ Preservation Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Solution
        • 7.3.1.2.2. By Technique
        • 7.3.1.2.3. By Organ Type
        • 7.3.1.2.4. By End User
    • 7.3.2. France Organ Preservation Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Solution
        • 7.3.2.2.2. By Technique
        • 7.3.2.2.3. By Organ Type
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Organ Preservation Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Solution
        • 7.3.3.2.2. By Technique
        • 7.3.3.2.3. By Organ Type
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Organ Preservation Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Solution
        • 7.3.4.2.2. By Technique
        • 7.3.4.2.3. By Organ Type
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Organ Preservation Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Solution
        • 7.3.5.2.2. By Technique
        • 7.3.5.2.3. By Organ Type
        • 7.3.5.2.4. By End User

8. Asia Pacific Organ Preservation Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Solution
    • 8.2.2. By Technique
    • 8.2.3. By Organ Type
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Organ Preservation Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Solution
        • 8.3.1.2.2. By Technique
        • 8.3.1.2.3. By Organ Type
        • 8.3.1.2.4. By End User
    • 8.3.2. India Organ Preservation Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Solution
        • 8.3.2.2.2. By Technique
        • 8.3.2.2.3. By Organ Type
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Organ Preservation Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Solution
        • 8.3.3.2.2. By Technique
        • 8.3.3.2.3. By Organ Type
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Organ Preservation Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Solution
        • 8.3.4.2.2. By Technique
        • 8.3.4.2.3. By Organ Type
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Organ Preservation Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Solution
        • 8.3.5.2.2. By Technique
        • 8.3.5.2.3. By Organ Type
        • 8.3.5.2.4. By End User

9. Middle East & Africa Organ Preservation Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Solution
    • 9.2.2. By Technique
    • 9.2.3. By Organ Type
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Organ Preservation Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Solution
        • 9.3.1.2.2. By Technique
        • 9.3.1.2.3. By Organ Type
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Organ Preservation Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Solution
        • 9.3.2.2.2. By Technique
        • 9.3.2.2.3. By Organ Type
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Organ Preservation Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Solution
        • 9.3.3.2.2. By Technique
        • 9.3.3.2.3. By Organ Type
        • 9.3.3.2.4. By End User

10. South America Organ Preservation Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Solution
    • 10.2.2. By Technique
    • 10.2.3. By Organ Type
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Organ Preservation Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Solution
        • 10.3.1.2.2. By Technique
        • 10.3.1.2.3. By Organ Type
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Organ Preservation Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Solution
        • 10.3.2.2.2. By Technique
        • 10.3.2.2.3. By Organ Type
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Organ Preservation Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Solution
        • 10.3.3.2.2. By Technique
        • 10.3.3.2.3. By Organ Type
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Organ Preservation Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Paragonix Technologies, Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. XVIVO Perfusion AB
  • 15.3. Dr. Franz KOhler Chemie GmbH
  • 15.4. OrganOx Limited
  • 15.5. Bridge to Life (Europe) Ltd.
  • 15.6. Waters Medical Systems, LLC
  • 15.7. Preservation Solutions Inc.
  • 15.8. Artivion, Inc
  • 15.9. Vascular Perfusion Solutions, Inc
  • 15.10. Global Transplant Solutions

16. Strategic Recommendations

17. About Us & Disclaimer